Dopamine Receptor d1 anticorps
Aperçu rapide pour Dopamine Receptor d1 anticorps (ABIN636878)
Antigène
Voir toutes Dopamine Receptor d1 (DRD1) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Purification
- Affinity chromatography purified
-
Immunogène
- DRD1 antibody was raised in rabbit using a synthetic peptide conjugated to KLH as the immunogen.
-
-
-
-
Indications d'application
-
IHC-P: 1-5 µg/mL
Optimal conditions should be determined by the investigator. -
Restrictions
- For Research Use only
-
-
-
Concentration
- Lot specific
-
Buffer
- Purified by Immunoaffinity Chromatography and supplied in PBS with 0.1 % NaN3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C for short term storage. Aliquot and store at -70 °C for long term storage.
-
-
- Dopamine Receptor d1 (DRD1) (Dopamine Receptor D1 (DRD1))
-
Autre désignation
- DRD1
-
Sujet
- Dopamine receptors are a class of metabotropic G protein-coupled receptors that are prominent in the vertebrate central nervous system (CNS). The neurotransmitter dopamine is the primary endogenous ligand for dopamine receptors. Activation of D1-like family receptors is coupled to the G protein G alphas, which subsequently activates adenylyl cyclase, increasing the intracellular concentration of the second messenger cyclic adenosine monophosphate (cAMP).
-
Pathways
- cAMP Metabolic Process, Inositol Metabolic Process, Protein targeting to Nucleus, Feeding Behaviour, Smooth Muscle Cell Migration, Regulation of long-term Neuronal Synaptic Plasticity
Antigène
-